Australian Macquarie Fund strike deal to acquire minority ownership in Luz Saúde
In a competitive and intriguing turn of events, the race to acquire a healthcare group valued at over one billion euros has seen a new leader emerge. According to reports by journalist Isabel Vicente, the Macquarie Group has overtaken CVC Capital Partners Plc and KKR & Co in this high-stakes business transaction.
The expected value of this healthcare group exceeds one billion euros, a significant figure that has attracted the attention of several major players in the industry. Among them are Investindustrial, Sanofi, CVC Capital Partners, and potentially, Isabel Vicente's reporting.
Investindustrial, recently cleared by the European Commission for its acquisition of DCC Healthcare, is one of the top contenders. Sanofi, known for its active role in notable acquisitions and expansions in 2025, such as Vigil Neuroscience and Blueprint Medicines, also stands out. CVC Capital Partners, with its acquisition of Cooper Consumer Health for about US$2.2 billion, demonstrates its strategic interest in large healthcare deals.
This acquisition is a significant event in the business world, marking a strategic move by the winning bidder to expand their healthcare portfolio through high-value acquisitions. Isabel Vicente, the journalist reporting on this transaction, has been covering the overtaking of CVC Capital Partners Plc and KKR & Co by Macquarie Group.
The acquisition race among these companies reflects their commitment to growth and innovation in the healthcare sector, a trend that has been evident in recent large deals exceeding the billion-euro mark. As the story unfolds, the business world eagerly awaits the final outcome of this high-stakes acquisition.
The detailed reporting by Isabel Vicente indicates that the large-scale acquisition of the healthcare group is a promising investment opportunity for various finance-driven entities. This competitive race among the Macquarie Group, Investindustrial, Sanofi, and others signifies a significant flow of funds towards healthcare finance.
